Healthcare provider profile · identity verified

Dewey Herbert Bridger, MD

Family Practice · WILMINGTON, NC · NPI 1386683944

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	975	262
Levothyroxine Sodium	Levothyroxine Sodium	461	121
Metoprolol Succinate	Metoprolol Succinate	437	134
Amlodipine Besylate	Amlodipine Besylate	332	88
Omeprazole	Omeprazole	325	91
Lisinopril	Lisinopril	313	90
Losartan Potassium	Losartan Potassium	296	73
Gabapentin	Gabapentin	284	73
Lorazepam	Lorazepam	269	68
Simvastatin	Simvastatin	263	70
Tamsulosin Hcl	Tamsulosin Hcl	261	78
Metformin Hcl	Metformin Hcl	245	69
Furosemide	Furosemide	238	78
Pantoprazole Sodium	Pantoprazole Sodium	235	73
Hydrochlorothiazide	Hydrochlorothiazide	233	64
Meloxicam	Meloxicam	215	73
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	213	56
Tramadol Hcl	Tramadol Hcl	210	79
Duloxetine Hcl	Duloxetine Hcl	200	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	197	49
Ozempic	Semaglutide	187	32
Alprazolam	Alprazolam	178	58
Rosuvastatin Calcium	Rosuvastatin Calcium	176	56
Albuterol Sulfate Hfa	Albuterol Sulfate	147	54
Potassium Chloride	Potassium Chloride	138	47
Sertraline Hcl	Sertraline Hcl	135	45
Fluticasone Propionate	Fluticasone Propionate	132	53
Memantine Hcl	Memantine Hcl	132	35
Allopurinol	Allopurinol	126	34
Clopidogrel	Clopidogrel Bisulfate	114	33
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	114	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	114	25
Clonazepam	Clonazepam	112	26
Celecoxib	Celecoxib	101	33
Zolpidem Tartrate	Zolpidem Tartrate	101	52
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	98	27
Pioglitazone Hcl	Pioglitazone Hcl	98	27
Oxycodone Hcl	Oxycodone Hcl	96	20
Fluoxetine Hcl	Fluoxetine Hcl	92	20
Escitalopram Oxalate	Escitalopram Oxalate	83	20
Metformin Hcl Er	Metformin Hcl	83	25
Valsartan	Valsartan	83	26
Glimepiride	Glimepiride	79	25
Montelukast Sodium	Montelukast Sodium	79	21
Pravastatin Sodium	Pravastatin Sodium	78	23
Alendronate Sodium	Alendronate Sodium	77	23
Atenolol	Atenolol	73	19
Metoprolol Tartrate	Metoprolol Tartrate	70	24
Diazepam	Diazepam	68	18
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	67	21
Propranolol Hcl Er	Propranolol Hcl	66	23
Synthroid	Levothyroxine Sodium	66	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	64	56
Finasteride	Finasteride	64	20
Trazodone Hcl	Trazodone Hcl	61	16
Fenofibrate	Fenofibrate	59	15
Donepezil Hcl	Donepezil Hcl	58	15
Eliquis	Apixaban	58	18
Xarelto	Rivaroxaban	57	15
Prednisone	Prednisone	55	38
Carvedilol	Carvedilol	53	13
Bupropion Xl	Bupropion Hcl	51	14
Temazepam	Temazepam	50	15
Paroxetine Hcl	Paroxetine Hcl	48	14
Topiramate	Topiramate	48	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	45	12
Ezetimibe	Ezetimibe	45	14
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	44	suppressed
Promethazine Hcl	Promethazine Hcl	42	suppressed
Baclofen	Baclofen	41	suppressed
Meclizine Hcl	Meclizine Hcl	41	17
Azithromycin	Azithromycin	39	37
Pregabalin	Pregabalin	39	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	39	27
Oxybutynin Chloride Er	Oxybutynin Chloride	38	14
Valacyclovir	Valacyclovir Hcl	38	25
Tizanidine Hcl	Tizanidine Hcl	37	22
Buspirone Hcl	Buspirone Hcl	36	12
Ondansetron Hcl	Ondansetron Hcl	36	15
Ventolin Hfa	Albuterol Sulfate	36	15
Triamcinolone Acetonide	Triamcinolone Acetonide	35	21
Ibuprofen	Ibuprofen	34	suppressed
Propranolol Hcl	Propranolol Hcl	34	suppressed
Estradiol	Estradiol	33	suppressed
Klor-Con M20	Potassium Chloride	33	15
Sumatriptan Succinate	Sumatriptan Succinate	33	12
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Ketoconazole	Ketoconazole	30	16
Spironolactone	Spironolactone	30	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Testosterone Cypionate	Testosterone Cypionate	29	15
Methocarbamol	Methocarbamol	28	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	28	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	24	12
Fludrocortisone Acetate	Fludrocortisone Acetate	24	suppressed
Hydralazine Hcl	Hydralazine Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Ramipril	Ramipril	23	suppressed
Anastrozole	Anastrozole	22	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	22	22
Colchicine	Colchicine	22	11
Linzess	Linaclotide	22	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	22	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	21	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	21	suppressed
Lamotrigine	Lamotrigine	21	suppressed
Morphine Sulfate Er	Morphine Sulfate	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Enalapril Maleate	Enalapril Maleate	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	19	19
Mirtazapine	Mirtazapine	19	suppressed
Naproxen	Naproxen	19	suppressed
Nitroglycerin	Nitroglycerin	19	suppressed
Fluconazole	Fluconazole	18	13
Bumetanide	Bumetanide	16	suppressed
Cephalexin	Cephalexin	16	14
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	16	suppressed
Liothyronine Sodium	Liothyronine Sodium	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Primidone	Primidone	16	suppressed
Mounjaro	Tirzepatide	15	suppressed
Testosterone	Testosterone	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	14	13
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Cimetidine	Cimetidine	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Dexilant	Dexlansoprazole	13	suppressed
Emgality Syringe	Galcanezumab-Gnlm	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Glipizide	Glipizide	13	suppressed
Indapamide	Indapamide	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Ubrelvy	Ubrogepant	13	suppressed
Cilostazol	Cilostazol	12	suppressed
Famotidine	Famotidine	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Motegrity	Prucalopride Succinate	12	suppressed
Mupirocin	Mupirocin	12	11
Asa-Butalb-Caffeine-Codeine	Codeine/Butalbital/Asa/Caffein	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed
Novolin R	Insulin Regular, Human	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error